Abstract
It is believed that in the coming years the natural history of hepatitis C virus (HCV) infection may be drastically modified due to the advent of direct-acting drugs with high rates of sustained virological response. In particular, with regard to the possibility of regression of liver fibrosis, even in more advanced stages of the disease, such as cirrhosis and complications. However, ther…